nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—PTGS2—type 2 diabetes mellitus	0.198	1	CbGaD
Tolmetin—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.0642	0.132	CbGbCtD
Tolmetin—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.0642	0.132	CbGbCtD
Tolmetin—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.0592	0.122	CbGbCtD
Tolmetin—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.0563	0.116	CbGbCtD
Tolmetin—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.0501	0.103	CbGbCtD
Tolmetin—PTGS1—Nateglinide—type 2 diabetes mellitus	0.0486	0.0998	CbGbCtD
Tolmetin—PTGS1—Irbesartan—type 2 diabetes mellitus	0.0466	0.0957	CbGbCtD
Tolmetin—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0426	0.0875	CbGbCtD
Tolmetin—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0288	0.0591	CbGbCtD
Tolmetin—SLC22A6—Losartan—type 2 diabetes mellitus	0.0263	0.0541	CbGbCtD
Tolmetin—MPO—artery—type 2 diabetes mellitus	0.00279	0.0811	CbGeAlD
Tolmetin—MPO—endothelium—type 2 diabetes mellitus	0.00236	0.0685	CbGeAlD
Tolmetin—PTGS2—leg—type 2 diabetes mellitus	0.00231	0.0672	CbGeAlD
Tolmetin—CXCL8—islet of Langerhans—type 2 diabetes mellitus	0.00229	0.0666	CbGeAlD
Tolmetin—PTGS2—hindlimb—type 2 diabetes mellitus	0.00206	0.06	CbGeAlD
Tolmetin—TDO2—liver—type 2 diabetes mellitus	0.00186	0.0541	CbGeAlD
Tolmetin—CXCL8—nephron tubule—type 2 diabetes mellitus	0.00185	0.0536	CbGeAlD
Tolmetin—CXCL8—pancreas—type 2 diabetes mellitus	0.00161	0.0468	CbGeAlD
Tolmetin—CXCL8—adipose tissue—type 2 diabetes mellitus	0.00146	0.0425	CbGeAlD
Tolmetin—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.00144	0.0419	CbGeAlD
Tolmetin—PTGS1—artery—type 2 diabetes mellitus	0.00132	0.0385	CbGeAlD
Tolmetin—PTGS2—artery—type 2 diabetes mellitus	0.00126	0.0368	CbGeAlD
Tolmetin—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.00123	0.0359	CbGeAlD
Tolmetin—PTGS1—endothelium—type 2 diabetes mellitus	0.00112	0.0325	CbGeAlD
Tolmetin—PTGS2—endothelium—type 2 diabetes mellitus	0.00107	0.0311	CbGeAlD
Tolmetin—CXCL8—liver—type 2 diabetes mellitus	0.00103	0.0298	CbGeAlD
Tolmetin—MPO—cardiovascular system—type 2 diabetes mellitus	0.000969	0.0282	CbGeAlD
Tolmetin—MPO—kidney—type 2 diabetes mellitus	0.000948	0.0276	CbGeAlD
Tolmetin—MPO—pancreas—type 2 diabetes mellitus	0.000942	0.0274	CbGeAlD
Tolmetin—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.000608	0.0177	CbGeAlD
Tolmetin—MPO—liver—type 2 diabetes mellitus	0.000599	0.0174	CbGeAlD
Tolmetin—Indomethacin—PPARA—type 2 diabetes mellitus	0.000592	0.142	CrCbGaD
Tolmetin—Zolpidem—CYP1A2—type 2 diabetes mellitus	0.000506	0.121	CrCbGaD
Tolmetin—PTGS1—cardiovascular system—type 2 diabetes mellitus	0.00046	0.0134	CbGeAlD
Tolmetin—PTGS1—kidney—type 2 diabetes mellitus	0.00045	0.0131	CbGeAlD
Tolmetin—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.00044	0.0128	CbGeAlD
Tolmetin—PTGS2—kidney—type 2 diabetes mellitus	0.00043	0.0125	CbGeAlD
Tolmetin—PTGS2—pancreas—type 2 diabetes mellitus	0.000427	0.0124	CbGeAlD
Tolmetin—PTGS1—adipose tissue—type 2 diabetes mellitus	0.000406	0.0118	CbGeAlD
Tolmetin—PTGS2—adipose tissue—type 2 diabetes mellitus	0.000388	0.0113	CbGeAlD
Tolmetin—Lumiracoxib—CYP1A2—type 2 diabetes mellitus	0.000383	0.092	CrCbGaD
Tolmetin—Oedema—Pioglitazone—type 2 diabetes mellitus	0.000367	0.00237	CcSEcCtD
Tolmetin—Urinary tract infection—Orlistat—type 2 diabetes mellitus	0.000367	0.00237	CcSEcCtD
Tolmetin—Abdominal pain—Repaglinide—type 2 diabetes mellitus	0.000366	0.00236	CcSEcCtD
Tolmetin—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.000366	0.00236	CcSEcCtD
Tolmetin—Headache—Tolazamide—type 2 diabetes mellitus	0.000362	0.00234	CcSEcCtD
Tolmetin—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000362	0.00234	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Losartan—type 2 diabetes mellitus	0.000361	0.00233	CcSEcCtD
Tolmetin—Epistaxis—Valsartan—type 2 diabetes mellitus	0.00036	0.00232	CcSEcCtD
Tolmetin—Visual impairment—Gliclazide—type 2 diabetes mellitus	0.000359	0.00232	CcSEcCtD
Tolmetin—Headache—Linagliptin—type 2 diabetes mellitus	0.000358	0.00231	CcSEcCtD
Tolmetin—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.000358	0.00231	CcSEcCtD
Tolmetin—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.000357	0.0023	CcSEcCtD
Tolmetin—Purpura—Ramipril—type 2 diabetes mellitus	0.000356	0.0023	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Ramipril—type 2 diabetes mellitus	0.000355	0.00229	CcSEcCtD
Tolmetin—Gastritis—Losartan—type 2 diabetes mellitus	0.000354	0.00229	CcSEcCtD
Tolmetin—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000354	0.00228	CcSEcCtD
Tolmetin—Vomiting—Acarbose—type 2 diabetes mellitus	0.000353	0.00228	CcSEcCtD
Tolmetin—Erythema multiforme—Gliclazide—type 2 diabetes mellitus	0.000353	0.00227	CcSEcCtD
Tolmetin—Thrombocytopenia—Glimepiride—type 2 diabetes mellitus	0.00035	0.00226	CcSEcCtD
Tolmetin—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.000348	0.00224	CcSEcCtD
Tolmetin—Tinnitus—Gliclazide—type 2 diabetes mellitus	0.000348	0.00224	CcSEcCtD
Tolmetin—Drowsiness—Metformin—type 2 diabetes mellitus	0.000348	0.00224	CcSEcCtD
Tolmetin—Nausea—Tolazamide—type 2 diabetes mellitus	0.000343	0.00221	CcSEcCtD
Tolmetin—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000343	0.00221	CcSEcCtD
Tolmetin—Hepatitis—Valsartan—type 2 diabetes mellitus	0.000343	0.00221	CcSEcCtD
Tolmetin—Somnolence—Glipizide—type 2 diabetes mellitus	0.000341	0.0022	CcSEcCtD
Tolmetin—Vomiting—Nateglinide—type 2 diabetes mellitus	0.00034	0.0022	CcSEcCtD
Tolmetin—Hepatitis—Orlistat—type 2 diabetes mellitus	0.000339	0.00218	CcSEcCtD
Tolmetin—Dyspepsia—Glipizide—type 2 diabetes mellitus	0.000337	0.00218	CcSEcCtD
Tolmetin—Zolpidem—CYP3A4—type 2 diabetes mellitus	0.000335	0.0804	CrCbGaD
Tolmetin—Weight increased—Irbesartan—type 2 diabetes mellitus	0.000335	0.00216	CcSEcCtD
Tolmetin—Nausea—Acarbose—type 2 diabetes mellitus	0.00033	0.00213	CcSEcCtD
Tolmetin—Constipation—Glipizide—type 2 diabetes mellitus	0.000328	0.00212	CcSEcCtD
Tolmetin—Oedema—Bromocriptine—type 2 diabetes mellitus	0.000323	0.00208	CcSEcCtD
Tolmetin—Renal failure—Irbesartan—type 2 diabetes mellitus	0.000322	0.00208	CcSEcCtD
Tolmetin—Flatulence—Gliclazide—type 2 diabetes mellitus	0.00032	0.00206	CcSEcCtD
Tolmetin—Urinary tract infection—Irbesartan—type 2 diabetes mellitus	0.000319	0.00206	CcSEcCtD
Tolmetin—Somnolence—Glimepiride—type 2 diabetes mellitus	0.000318	0.00205	CcSEcCtD
Tolmetin—Nausea—Nateglinide—type 2 diabetes mellitus	0.000318	0.00205	CcSEcCtD
Tolmetin—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.000317	0.00205	CcSEcCtD
Tolmetin—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000317	0.00205	CcSEcCtD
Tolmetin—Weight increased—Losartan—type 2 diabetes mellitus	0.000315	0.00203	CcSEcCtD
Tolmetin—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.000315	0.00203	CcSEcCtD
Tolmetin—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000314	0.00203	CcSEcCtD
Tolmetin—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000314	0.00203	CcSEcCtD
Tolmetin—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.000313	0.00202	CcSEcCtD
Tolmetin—Hepatitis—Metformin—type 2 diabetes mellitus	0.000312	0.00201	CcSEcCtD
Tolmetin—Epistaxis—Irbesartan—type 2 diabetes mellitus	0.000309	0.002	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Ramipril—type 2 diabetes mellitus	0.000309	0.002	CcSEcCtD
Tolmetin—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000306	0.00197	CcSEcCtD
Tolmetin—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000305	0.00197	CcSEcCtD
Tolmetin—Ketorolac—PTGS2—type 2 diabetes mellitus	0.000305	0.0732	CrCbGaD
Tolmetin—Urticaria—Glipizide—type 2 diabetes mellitus	0.000305	0.00196	CcSEcCtD
Tolmetin—Gastritis—Ramipril—type 2 diabetes mellitus	0.000304	0.00196	CcSEcCtD
Tolmetin—Renal failure—Losartan—type 2 diabetes mellitus	0.000303	0.00196	CcSEcCtD
Tolmetin—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000303	0.00196	CcSEcCtD
Tolmetin—Aminohippurate—ABCC2—type 2 diabetes mellitus	0.000302	0.0724	CrCbGaD
Tolmetin—Urinary tract infection—Losartan—type 2 diabetes mellitus	0.0003	0.00194	CcSEcCtD
Tolmetin—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.0003	0.00193	CcSEcCtD
Tolmetin—Oedema—Glyburide—type 2 diabetes mellitus	0.000295	0.0019	CcSEcCtD
Tolmetin—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000295	0.0019	CcSEcCtD
Tolmetin—Hepatitis—Irbesartan—type 2 diabetes mellitus	0.000294	0.0019	CcSEcCtD
Tolmetin—Flatulence—Valsartan—type 2 diabetes mellitus	0.000294	0.0019	CcSEcCtD
Tolmetin—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000293	0.00189	CcSEcCtD
Tolmetin—Bromfenac—PTGS2—type 2 diabetes mellitus	0.000292	0.0702	CrCbGaD
Tolmetin—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000292	0.00188	CcSEcCtD
Tolmetin—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000292	0.00188	CcSEcCtD
Tolmetin—Epistaxis—Losartan—type 2 diabetes mellitus	0.000291	0.00188	CcSEcCtD
Tolmetin—Flatulence—Orlistat—type 2 diabetes mellitus	0.00029	0.00187	CcSEcCtD
Tolmetin—Headache—Repaglinide—type 2 diabetes mellitus	0.00029	0.00187	CcSEcCtD
Tolmetin—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00029	0.00187	CcSEcCtD
Tolmetin—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000289	0.00186	CcSEcCtD
Tolmetin—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000288	0.00186	CcSEcCtD
Tolmetin—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000287	0.00185	CcSEcCtD
Tolmetin—Abdominal discomfort—Ramipril—type 2 diabetes mellitus	0.000285	0.00184	CcSEcCtD
Tolmetin—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000284	0.00183	CcSEcCtD
Tolmetin—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000284	0.00183	CcSEcCtD
Tolmetin—Visual impairment—Irbesartan—type 2 diabetes mellitus	0.000284	0.00183	CcSEcCtD
Tolmetin—Indomethacin—PPARG—type 2 diabetes mellitus	0.000284	0.0681	CrCbGaD
Tolmetin—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000283	0.00183	CcSEcCtD
Tolmetin—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000283	0.00182	CcSEcCtD
Tolmetin—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000282	0.00182	CcSEcCtD
Tolmetin—Hepatitis—Losartan—type 2 diabetes mellitus	0.000277	0.00179	CcSEcCtD
Tolmetin—Indomethacin—ABCC2—type 2 diabetes mellitus	0.000277	0.0665	CrCbGaD
Tolmetin—Chest pain—Gliclazide—type 2 diabetes mellitus	0.000276	0.00178	CcSEcCtD
Tolmetin—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000276	0.00178	CcSEcCtD
Tolmetin—Nausea—Repaglinide—type 2 diabetes mellitus	0.000275	0.00178	CcSEcCtD
Tolmetin—Asthenia—Glipizide—type 2 diabetes mellitus	0.000275	0.00177	CcSEcCtD
Tolmetin—Tinnitus—Irbesartan—type 2 diabetes mellitus	0.000275	0.00177	CcSEcCtD
Tolmetin—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000274	0.00177	CcSEcCtD
Tolmetin—PTGS2—liver—type 2 diabetes mellitus	0.000272	0.0079	CbGeAlD
Tolmetin—Weight increased—Ramipril—type 2 diabetes mellitus	0.00027	0.00174	CcSEcCtD
Tolmetin—Flatulence—Metformin—type 2 diabetes mellitus	0.000268	0.00173	CcSEcCtD
Tolmetin—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000264	0.0017	CcSEcCtD
Tolmetin—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000263	0.0017	CcSEcCtD
Tolmetin—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000262	0.00169	CcSEcCtD
Tolmetin—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000262	0.00169	CcSEcCtD
Tolmetin—Renal failure—Ramipril—type 2 diabetes mellitus	0.00026	0.00168	CcSEcCtD
Tolmetin—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00026	0.00168	CcSEcCtD
Tolmetin—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.00026	0.00168	CcSEcCtD
Tolmetin—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000259	0.00167	CcSEcCtD
Tolmetin—Tinnitus—Losartan—type 2 diabetes mellitus	0.000258	0.00167	CcSEcCtD
Tolmetin—Stomatitis—Ramipril—type 2 diabetes mellitus	0.000258	0.00166	CcSEcCtD
Tolmetin—Urinary tract infection—Ramipril—type 2 diabetes mellitus	0.000257	0.00166	CcSEcCtD
Tolmetin—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000257	0.00166	CcSEcCtD
Tolmetin—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000256	0.00165	CcSEcCtD
Tolmetin—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000256	0.00165	CcSEcCtD
Tolmetin—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000255	0.00165	CcSEcCtD
Tolmetin—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000255	0.00165	CcSEcCtD
Tolmetin—Chest pain—Valsartan—type 2 diabetes mellitus	0.000254	0.00164	CcSEcCtD
Tolmetin—Dizziness—Glipizide—type 2 diabetes mellitus	0.000253	0.00164	CcSEcCtD
Tolmetin—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000253	0.00163	CcSEcCtD
Tolmetin—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000251	0.00162	CcSEcCtD
Tolmetin—Chest pain—Orlistat—type 2 diabetes mellitus	0.000251	0.00162	CcSEcCtD
Tolmetin—Epistaxis—Ramipril—type 2 diabetes mellitus	0.00025	0.00161	CcSEcCtD
Tolmetin—Lumiracoxib—PTGS2—type 2 diabetes mellitus	0.000248	0.0597	CrCbGaD
Tolmetin—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000247	0.00159	CcSEcCtD
Tolmetin—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000245	0.00158	CcSEcCtD
Tolmetin—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000244	0.00157	CcSEcCtD
Tolmetin—Vomiting—Glipizide—type 2 diabetes mellitus	0.000244	0.00157	CcSEcCtD
Tolmetin—Oedema—Valsartan—type 2 diabetes mellitus	0.000243	0.00157	CcSEcCtD
Tolmetin—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000243	0.00157	CcSEcCtD
Tolmetin—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000243	0.00157	CcSEcCtD
Tolmetin—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000241	0.00156	CcSEcCtD
Tolmetin—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000241	0.00155	CcSEcCtD
Tolmetin—Oedema—Orlistat—type 2 diabetes mellitus	0.000241	0.00155	CcSEcCtD
Tolmetin—Headache—Glipizide—type 2 diabetes mellitus	0.00024	0.00155	CcSEcCtD
Tolmetin—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000238	0.00154	CcSEcCtD
Tolmetin—Flatulence—Losartan—type 2 diabetes mellitus	0.000238	0.00153	CcSEcCtD
Tolmetin—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000238	0.00153	CcSEcCtD
Tolmetin—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000237	0.00153	CcSEcCtD
Tolmetin—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000236	0.00152	CcSEcCtD
Tolmetin—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000236	0.00152	CcSEcCtD
Tolmetin—Urticaria—Glyburide—type 2 diabetes mellitus	0.000234	0.00151	CcSEcCtD
Tolmetin—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000233	0.0015	CcSEcCtD
Tolmetin—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000233	0.0015	CcSEcCtD
Tolmetin—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000232	0.00149	CcSEcCtD
Tolmetin—Chest pain—Metformin—type 2 diabetes mellitus	0.000231	0.00149	CcSEcCtD
Tolmetin—Headache—Pioglitazone—type 2 diabetes mellitus	0.00023	0.00148	CcSEcCtD
Tolmetin—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000229	0.00148	CcSEcCtD
Tolmetin—Nausea—Glipizide—type 2 diabetes mellitus	0.000228	0.00147	CcSEcCtD
Tolmetin—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000227	0.00147	CcSEcCtD
Tolmetin—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000227	0.00146	CcSEcCtD
Tolmetin—Constipation—Gliclazide—type 2 diabetes mellitus	0.000227	0.00146	CcSEcCtD
Tolmetin—Fenbufen—PTGS2—type 2 diabetes mellitus	0.000226	0.0543	CrCbGaD
Tolmetin—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000225	0.00145	CcSEcCtD
Tolmetin—Headache—Glimepiride—type 2 diabetes mellitus	0.000224	0.00145	CcSEcCtD
Tolmetin—Headache—Sitagliptin—type 2 diabetes mellitus	0.000223	0.00144	CcSEcCtD
Tolmetin—Oedema—Metformin—type 2 diabetes mellitus	0.000222	0.00143	CcSEcCtD
Tolmetin—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000222	0.00143	CcSEcCtD
Tolmetin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000221	0.00142	CcSEcCtD
Tolmetin—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000218	0.00141	CcSEcCtD
Tolmetin—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000217	0.0014	CcSEcCtD
Tolmetin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000217	0.0014	CcSEcCtD
Tolmetin—Somnolence—Valsartan—type 2 diabetes mellitus	0.000216	0.0014	CcSEcCtD
Tolmetin—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000214	0.00138	CcSEcCtD
Tolmetin—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000213	0.00138	CcSEcCtD
Tolmetin—Nausea—Glimepiride—type 2 diabetes mellitus	0.000212	0.00137	CcSEcCtD
Tolmetin—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000212	0.00137	CcSEcCtD
Tolmetin—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000212	0.00137	CcSEcCtD
Tolmetin—Asthenia—Glyburide—type 2 diabetes mellitus	0.000212	0.00137	CcSEcCtD
Tolmetin—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00021	0.00136	CcSEcCtD
Tolmetin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000209	0.00135	CcSEcCtD
Tolmetin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000209	0.00135	CcSEcCtD
Tolmetin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000209	0.00135	CcSEcCtD
Tolmetin—Oedema—Irbesartan—type 2 diabetes mellitus	0.000209	0.00135	CcSEcCtD
Tolmetin—Constipation—Valsartan—type 2 diabetes mellitus	0.000208	0.00134	CcSEcCtD
Tolmetin—Chest pain—Losartan—type 2 diabetes mellitus	0.000205	0.00132	CcSEcCtD
Tolmetin—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000205	0.00132	CcSEcCtD
Tolmetin—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000205	0.00132	CcSEcCtD
Tolmetin—Headache—Bromocriptine—type 2 diabetes mellitus	0.000202	0.0013	CcSEcCtD
Tolmetin—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000202	0.0013	CcSEcCtD
Tolmetin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000199	0.00128	CcSEcCtD
Tolmetin—Somnolence—Metformin—type 2 diabetes mellitus	0.000197	0.00127	CcSEcCtD
Tolmetin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000197	0.00127	CcSEcCtD
Tolmetin—Oedema—Losartan—type 2 diabetes mellitus	0.000197	0.00127	CcSEcCtD
Tolmetin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000197	0.00127	CcSEcCtD
Tolmetin—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000195	0.00126	CcSEcCtD
Tolmetin—Urticaria—Valsartan—type 2 diabetes mellitus	0.000193	0.00125	CcSEcCtD
Tolmetin—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000193	0.00124	CcSEcCtD
Tolmetin—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000192	0.00124	CcSEcCtD
Tolmetin—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000192	0.00124	CcSEcCtD
Tolmetin—Urticaria—Orlistat—type 2 diabetes mellitus	0.000191	0.00123	CcSEcCtD
Tolmetin—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.00019	0.00123	CcSEcCtD
Tolmetin—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00019	0.00123	CcSEcCtD
Tolmetin—Asthenia—Gliclazide—type 2 diabetes mellitus	0.00019	0.00123	CcSEcCtD
Tolmetin—Constipation—Metformin—type 2 diabetes mellitus	0.00019	0.00122	CcSEcCtD
Tolmetin—Suprofen—PTGS2—type 2 diabetes mellitus	0.000188	0.0452	CrCbGaD
Tolmetin—Vomiting—Glyburide—type 2 diabetes mellitus	0.000188	0.00121	CcSEcCtD
Tolmetin—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000186	0.0012	CcSEcCtD
Tolmetin—Headache—Glyburide—type 2 diabetes mellitus	0.000185	0.00119	CcSEcCtD
Tolmetin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000184	0.00119	CcSEcCtD
Tolmetin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000181	0.00117	CcSEcCtD
Tolmetin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000181	0.00117	CcSEcCtD
Tolmetin—Constipation—Irbesartan—type 2 diabetes mellitus	0.000179	0.00115	CcSEcCtD
Tolmetin—Urticaria—Metformin—type 2 diabetes mellitus	0.000176	0.00114	CcSEcCtD
Tolmetin—Chest pain—Ramipril—type 2 diabetes mellitus	0.000176	0.00114	CcSEcCtD
Tolmetin—Nausea—Glyburide—type 2 diabetes mellitus	0.000175	0.00113	CcSEcCtD
Tolmetin—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000175	0.00113	CcSEcCtD
Tolmetin—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000175	0.00113	CcSEcCtD
Tolmetin—Somnolence—Losartan—type 2 diabetes mellitus	0.000175	0.00113	CcSEcCtD
Tolmetin—Asthenia—Valsartan—type 2 diabetes mellitus	0.000175	0.00113	CcSEcCtD
Tolmetin—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000173	0.00112	CcSEcCtD
Tolmetin—Asthenia—Orlistat—type 2 diabetes mellitus	0.000173	0.00111	CcSEcCtD
Tolmetin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000171	0.0011	CcSEcCtD
Tolmetin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000169	0.00109	CcSEcCtD
Tolmetin—Oedema—Ramipril—type 2 diabetes mellitus	0.000169	0.00109	CcSEcCtD
Tolmetin—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000168	0.00109	CcSEcCtD
Tolmetin—Constipation—Losartan—type 2 diabetes mellitus	0.000168	0.00109	CcSEcCtD
Tolmetin—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000167	0.00107	CcSEcCtD
Tolmetin—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000166	0.00107	CcSEcCtD
Tolmetin—Headache—Gliclazide—type 2 diabetes mellitus	0.000166	0.00107	CcSEcCtD
Tolmetin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000165	0.00107	CcSEcCtD
Tolmetin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000165	0.00107	CcSEcCtD
Tolmetin—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000165	0.00107	CcSEcCtD
Tolmetin—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000165	0.00106	CcSEcCtD
Tolmetin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000161	0.00104	CcSEcCtD
Tolmetin—Dizziness—Valsartan—type 2 diabetes mellitus	0.000161	0.00104	CcSEcCtD
Tolmetin—Dizziness—Orlistat—type 2 diabetes mellitus	0.000159	0.00103	CcSEcCtD
Tolmetin—Asthenia—Metformin—type 2 diabetes mellitus	0.000159	0.00103	CcSEcCtD
Tolmetin—Nausea—Gliclazide—type 2 diabetes mellitus	0.000157	0.00102	CcSEcCtD
Tolmetin—Urticaria—Losartan—type 2 diabetes mellitus	0.000156	0.00101	CcSEcCtD
Tolmetin—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000156	0.001	CcSEcCtD
Tolmetin—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000156	0.001	CcSEcCtD
Tolmetin—Vomiting—Valsartan—type 2 diabetes mellitus	0.000155	0.000998	CcSEcCtD
Tolmetin—Vomiting—Orlistat—type 2 diabetes mellitus	0.000153	0.000987	CcSEcCtD
Tolmetin—Headache—Valsartan—type 2 diabetes mellitus	0.000152	0.000984	CcSEcCtD
Tolmetin—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000152	0.000978	CcSEcCtD
Tolmetin—Headache—Orlistat—type 2 diabetes mellitus	0.000151	0.000972	CcSEcCtD
Tolmetin—Asthenia—Irbesartan—type 2 diabetes mellitus	0.00015	0.000968	CcSEcCtD
Tolmetin—Somnolence—Ramipril—type 2 diabetes mellitus	0.00015	0.000968	CcSEcCtD
Tolmetin—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000149	0.000959	CcSEcCtD
Tolmetin—Dizziness—Metformin—type 2 diabetes mellitus	0.000147	0.000946	CcSEcCtD
Tolmetin—Nausea—Valsartan—type 2 diabetes mellitus	0.000145	0.000933	CcSEcCtD
Tolmetin—Constipation—Ramipril—type 2 diabetes mellitus	0.000144	0.000931	CcSEcCtD
Tolmetin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000143	0.000923	CcSEcCtD
Tolmetin—Nausea—Orlistat—type 2 diabetes mellitus	0.000143	0.000922	CcSEcCtD
Tolmetin—Asthenia—Losartan—type 2 diabetes mellitus	0.000141	0.000911	CcSEcCtD
Tolmetin—Vomiting—Metformin—type 2 diabetes mellitus	0.000141	0.000909	CcSEcCtD
Tolmetin—Headache—Metformin—type 2 diabetes mellitus	0.000139	0.000896	CcSEcCtD
Tolmetin—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000138	0.000892	CcSEcCtD
Tolmetin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000138	0.000891	CcSEcCtD
Tolmetin—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000135	0.000869	CcSEcCtD
Tolmetin—Urticaria—Ramipril—type 2 diabetes mellitus	0.000134	0.000865	CcSEcCtD
Tolmetin—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000133	0.000861	CcSEcCtD
Tolmetin—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000133	0.000861	CcSEcCtD
Tolmetin—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000133	0.000858	CcSEcCtD
Tolmetin—Nausea—Metformin—type 2 diabetes mellitus	0.000132	0.000849	CcSEcCtD
Tolmetin—Headache—Irbesartan—type 2 diabetes mellitus	0.000131	0.000845	CcSEcCtD
Tolmetin—Dizziness—Losartan—type 2 diabetes mellitus	0.00013	0.00084	CcSEcCtD
Tolmetin—Vomiting—Losartan—type 2 diabetes mellitus	0.000125	0.000808	CcSEcCtD
Tolmetin—Nausea—Irbesartan—type 2 diabetes mellitus	0.000124	0.000802	CcSEcCtD
Tolmetin—Headache—Losartan—type 2 diabetes mellitus	0.000123	0.000796	CcSEcCtD
Tolmetin—Asthenia—Ramipril—type 2 diabetes mellitus	0.000121	0.000781	CcSEcCtD
Tolmetin—Indomethacin—PTGS2—type 2 diabetes mellitus	0.00012	0.0288	CrCbGaD
Tolmetin—Nausea—Losartan—type 2 diabetes mellitus	0.000117	0.000754	CcSEcCtD
Tolmetin—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000115	0.000745	CcSEcCtD
Tolmetin—Dizziness—Ramipril—type 2 diabetes mellitus	0.000112	0.00072	CcSEcCtD
Tolmetin—Vomiting—Ramipril—type 2 diabetes mellitus	0.000107	0.000692	CcSEcCtD
Tolmetin—Indomethacin—ALB—type 2 diabetes mellitus	0.000107	0.0256	CrCbGaD
Tolmetin—Headache—Ramipril—type 2 diabetes mellitus	0.000106	0.000682	CcSEcCtD
Tolmetin—Nausea—Ramipril—type 2 diabetes mellitus	0.0001	0.000647	CcSEcCtD
Tolmetin—PTGS1—Metabolism—HK1—type 2 diabetes mellitus	1.74e-05	0.000143	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.74e-05	0.000143	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	1.73e-05	0.000143	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.73e-05	0.000142	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.72e-05	0.000142	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.72e-05	0.000142	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TLE4—type 2 diabetes mellitus	1.71e-05	0.000141	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.7e-05	0.00014	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ABCC8—type 2 diabetes mellitus	1.69e-05	0.000139	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CBS—type 2 diabetes mellitus	1.69e-05	0.000139	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—KCNJ11—type 2 diabetes mellitus	1.68e-05	0.000139	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.68e-05	0.000139	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GCKR—type 2 diabetes mellitus	1.68e-05	0.000139	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—LPA—type 2 diabetes mellitus	1.68e-05	0.000139	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.65e-05	0.000136	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HK1—type 2 diabetes mellitus	1.65e-05	0.000136	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—COX2—type 2 diabetes mellitus	1.62e-05	0.000134	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SLC5A2—type 2 diabetes mellitus	1.62e-05	0.000134	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.62e-05	0.000133	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	1.61e-05	0.000133	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ALDOB—type 2 diabetes mellitus	1.61e-05	0.000133	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.6e-05	0.000132	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL6—type 2 diabetes mellitus	1.6e-05	0.000132	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—NCOA6—type 2 diabetes mellitus	1.6e-05	0.000132	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.59e-05	0.000132	CbGpPWpGaD
Tolmetin—PTGS2—Disease—GCKR—type 2 diabetes mellitus	1.59e-05	0.000131	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.59e-05	0.000131	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	1.57e-05	0.00013	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.57e-05	0.00013	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GCG—type 2 diabetes mellitus	1.57e-05	0.00013	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—UCP3—type 2 diabetes mellitus	1.57e-05	0.000129	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—HSD11B1—type 2 diabetes mellitus	1.57e-05	0.000129	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—UCP2—type 2 diabetes mellitus	1.57e-05	0.000129	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.56e-05	0.000129	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.55e-05	0.000128	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.54e-05	0.000127	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.53e-05	0.000126	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ALDOB—type 2 diabetes mellitus	1.53e-05	0.000126	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.52e-05	0.000125	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.52e-05	0.000125	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GLP1R—type 2 diabetes mellitus	1.5e-05	0.000123	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PCK1—type 2 diabetes mellitus	1.47e-05	0.000122	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.47e-05	0.000121	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SPRY2—type 2 diabetes mellitus	1.46e-05	0.00012	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.45e-05	0.00012	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.45e-05	0.000119	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.44e-05	0.000119	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	1.44e-05	0.000119	CbGpPWpGaD
Tolmetin—PTGS2—Disease—RBP4—type 2 diabetes mellitus	1.42e-05	0.000117	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.42e-05	0.000117	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	1.42e-05	0.000117	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.41e-05	0.000116	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.4e-05	0.000115	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—HK1—type 2 diabetes mellitus	1.38e-05	0.000114	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.38e-05	0.000114	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CPT1A—type 2 diabetes mellitus	1.37e-05	0.000113	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—MTR—type 2 diabetes mellitus	1.37e-05	0.000113	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.37e-05	0.000113	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.36e-05	0.000112	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	1.35e-05	0.000111	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—NAMPT—type 2 diabetes mellitus	1.34e-05	0.000111	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AVP—type 2 diabetes mellitus	1.34e-05	0.00011	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.34e-05	0.00011	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.34e-05	0.00011	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—LIPC—type 2 diabetes mellitus	1.33e-05	0.00011	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—HBA1—type 2 diabetes mellitus	1.33e-05	0.00011	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GCK—type 2 diabetes mellitus	1.33e-05	0.00011	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GCKR—type 2 diabetes mellitus	1.33e-05	0.00011	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—HSD3B2—type 2 diabetes mellitus	1.33e-05	0.00011	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—LPA—type 2 diabetes mellitus	1.33e-05	0.00011	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—KCNJ11—type 2 diabetes mellitus	1.33e-05	0.00011	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.33e-05	0.00011	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.33e-05	0.000109	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.33e-05	0.000109	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SLC2A2—type 2 diabetes mellitus	1.33e-05	0.000109	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.31e-05	0.000108	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.3e-05	0.000107	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MTR—type 2 diabetes mellitus	1.3e-05	0.000107	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—APOB—type 2 diabetes mellitus	1.29e-05	0.000107	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CETP—type 2 diabetes mellitus	1.29e-05	0.000106	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.29e-05	0.000106	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.28e-05	0.000106	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ALDOB—type 2 diabetes mellitus	1.28e-05	0.000105	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NAMPT—type 2 diabetes mellitus	1.27e-05	0.000105	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.27e-05	0.000105	CbGpPWpGaD
Tolmetin—PTGS2—Disease—GCK—type 2 diabetes mellitus	1.27e-05	0.000104	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IAPP—type 2 diabetes mellitus	1.26e-05	0.000104	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.24e-05	0.000102	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SLC9A1—type 2 diabetes mellitus	1.23e-05	0.000102	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—LPL—type 2 diabetes mellitus	1.23e-05	0.000102	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.22e-05	0.0001	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.21e-05	9.96e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.2e-05	9.92e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.2e-05	9.9e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SREBF1—type 2 diabetes mellitus	1.2e-05	9.87e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PSMD6—type 2 diabetes mellitus	1.2e-05	9.87e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SNAP25—type 2 diabetes mellitus	1.2e-05	9.87e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GLP1R—type 2 diabetes mellitus	1.19e-05	9.8e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CTGF—type 2 diabetes mellitus	1.17e-05	9.69e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—HMGCR—type 2 diabetes mellitus	1.16e-05	9.6e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.16e-05	9.55e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HMGA1—type 2 diabetes mellitus	1.16e-05	9.54e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.15e-05	9.47e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.14e-05	9.4e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.14e-05	9.38e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PSMD6—type 2 diabetes mellitus	1.13e-05	9.36e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SNAP25—type 2 diabetes mellitus	1.13e-05	9.36e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—C3—type 2 diabetes mellitus	1.11e-05	9.16e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SLC2A2—type 2 diabetes mellitus	1.11e-05	9.15e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CYBA—type 2 diabetes mellitus	1.1e-05	9.06e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.09e-05	9.03e-05	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—AKT1—type 2 diabetes mellitus	1.09e-05	9.02e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—MTR—type 2 diabetes mellitus	1.09e-05	8.97e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CPT1A—type 2 diabetes mellitus	1.09e-05	8.97e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.08e-05	8.93e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.08e-05	8.93e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—NAMPT—type 2 diabetes mellitus	1.07e-05	8.79e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CALCA—type 2 diabetes mellitus	1.06e-05	8.76e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.06e-05	8.74e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.06e-05	8.74e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—HBA1—type 2 diabetes mellitus	1.06e-05	8.74e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—LIPC—type 2 diabetes mellitus	1.06e-05	8.74e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GCK—type 2 diabetes mellitus	1.06e-05	8.74e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.06e-05	8.72e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AGT—type 2 diabetes mellitus	1.06e-05	8.71e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.06e-05	8.71e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP11A1—type 2 diabetes mellitus	1.05e-05	8.68e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.05e-05	8.66e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.04e-05	8.56e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GCG—type 2 diabetes mellitus	1.04e-05	8.56e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.04e-05	8.56e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—LEP—type 2 diabetes mellitus	1.03e-05	8.53e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—APOE—type 2 diabetes mellitus	1.03e-05	8.53e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SLC9A1—type 2 diabetes mellitus	1.03e-05	8.53e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SLC2A1—type 2 diabetes mellitus	1.03e-05	8.46e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.02e-05	8.43e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CETP—type 2 diabetes mellitus	1.02e-05	8.43e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NOS1—type 2 diabetes mellitus	1.01e-05	8.34e-05	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1e-05	8.28e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TCF7L2—type 2 diabetes mellitus	1e-05	8.25e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SLC2A4—type 2 diabetes mellitus	9.84e-06	8.11e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PRKCB—type 2 diabetes mellitus	9.76e-06	8.05e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	9.53e-06	7.86e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SNAP25—type 2 diabetes mellitus	9.5e-06	7.84e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PSMD6—type 2 diabetes mellitus	9.5e-06	7.84e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SREBF1—type 2 diabetes mellitus	9.5e-06	7.84e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CTGF—type 2 diabetes mellitus	9.33e-06	7.69e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—HMGCR—type 2 diabetes mellitus	9.24e-06	7.62e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IRS1—type 2 diabetes mellitus	9.23e-06	7.61e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	9.12e-06	7.52e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ADRA2A—type 2 diabetes mellitus	9.05e-06	7.46e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.95e-06	7.38e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GNB3—type 2 diabetes mellitus	8.95e-06	7.38e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—HMOX1—type 2 diabetes mellitus	8.9e-06	7.34e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—INS—type 2 diabetes mellitus	8.84e-06	7.29e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CAT—type 2 diabetes mellitus	8.79e-06	7.25e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.69e-06	7.17e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP2E1—type 2 diabetes mellitus	8.69e-06	7.17e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP1A2—type 2 diabetes mellitus	8.59e-06	7.09e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SLC2A1—type 2 diabetes mellitus	8.59e-06	7.09e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TGFBR2—type 2 diabetes mellitus	8.56e-06	7.06e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IGF1—type 2 diabetes mellitus	8.55e-06	7.05e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AKT2—type 2 diabetes mellitus	8.54e-06	7.04e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—APOB—type 2 diabetes mellitus	8.53e-06	7.03e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—EGFR—type 2 diabetes mellitus	8.51e-06	7.02e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP3A4—type 2 diabetes mellitus	8.38e-06	6.91e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GSTM1—type 2 diabetes mellitus	8.3e-06	6.84e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CDKN2B—type 2 diabetes mellitus	8.29e-06	6.84e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GCG—type 2 diabetes mellitus	8.24e-06	6.8e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SLC2A4—type 2 diabetes mellitus	8.24e-06	6.8e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—LPL—type 2 diabetes mellitus	8.14e-06	6.72e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.12e-06	6.69e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—APOB—type 2 diabetes mellitus	8.08e-06	6.67e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ADCY5—type 2 diabetes mellitus	7.97e-06	6.58e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GPX1—type 2 diabetes mellitus	7.95e-06	6.55e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.75e-06	6.39e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.75e-06	6.39e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CD36—type 2 diabetes mellitus	7.74e-06	6.38e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—LPL—type 2 diabetes mellitus	7.72e-06	6.37e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PPP2CA—type 2 diabetes mellitus	7.64e-06	6.3e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ADCY5—type 2 diabetes mellitus	7.56e-06	6.23e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—MTHFR—type 2 diabetes mellitus	7.33e-06	6.05e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—RELA—type 2 diabetes mellitus	7.29e-06	6.02e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PPP2CA—type 2 diabetes mellitus	7.24e-06	5.97e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PPARA—type 2 diabetes mellitus	7.19e-06	5.93e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CCR5—type 2 diabetes mellitus	7.11e-06	5.87e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GNB3—type 2 diabetes mellitus	7.1e-06	5.86e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.1e-06	5.86e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—HMOX1—type 2 diabetes mellitus	7.07e-06	5.83e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CAT—type 2 diabetes mellitus	6.97e-06	5.75e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—AGT—type 2 diabetes mellitus	6.97e-06	5.75e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MTHFR—type 2 diabetes mellitus	6.95e-06	5.73e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CALM1—type 2 diabetes mellitus	6.85e-06	5.65e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—APOE—type 2 diabetes mellitus	6.83e-06	5.63e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	6.77e-06	5.58e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	6.75e-06	5.57e-05	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.64e-06	5.48e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	6.63e-06	5.47e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IRS2—type 2 diabetes mellitus	6.61e-06	5.45e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	6.59e-06	5.43e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.58e-06	5.43e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.54e-06	5.39e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CALM1—type 2 diabetes mellitus	6.49e-06	5.36e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—APOE—type 2 diabetes mellitus	6.47e-06	5.34e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	6.47e-06	5.33e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—APOA1—type 2 diabetes mellitus	6.4e-06	5.28e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	6.33e-06	5.22e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	6.31e-06	5.2e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.22e-06	5.13e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.15e-06	5.07e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	6.14e-06	5.07e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	6.07e-06	5e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.03e-06	4.97e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NOS2—type 2 diabetes mellitus	6.03e-06	4.97e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	5.95e-06	4.9e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—INS—type 2 diabetes mellitus	5.83e-06	4.81e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	5.82e-06	4.8e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IRS1—type 2 diabetes mellitus	5.77e-06	4.76e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SRC—type 2 diabetes mellitus	5.73e-06	4.73e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	5.71e-06	4.71e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.58e-06	4.6e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	5.53e-06	4.56e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—INS—type 2 diabetes mellitus	5.53e-06	4.56e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	5.44e-06	4.49e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	5.42e-06	4.47e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	5.36e-06	4.42e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	5.35e-06	4.41e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—AKT2—type 2 diabetes mellitus	5.34e-06	4.41e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.12e-06	4.23e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	5.11e-06	4.22e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	5.11e-06	4.22e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	5.08e-06	4.19e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.02e-06	4.14e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	4.85e-06	4e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NOS3—type 2 diabetes mellitus	4.85e-06	4e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	4.72e-06	3.89e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	4.68e-06	3.86e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—INS—type 2 diabetes mellitus	4.63e-06	3.82e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	4.24e-06	3.5e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	4.06e-06	3.35e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	4.06e-06	3.35e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL6—type 2 diabetes mellitus	3.86e-06	3.18e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SRC—type 2 diabetes mellitus	3.59e-06	2.96e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.56e-06	2.94e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	3.21e-06	2.64e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—EGFR—type 2 diabetes mellitus	3.14e-06	2.59e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IL6—type 2 diabetes mellitus	2.42e-06	1.99e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	2.35e-06	1.94e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—AKT1—type 2 diabetes mellitus	2.23e-06	1.84e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	1.87e-06	1.54e-05	CbGpPWpGaD
